• α-Bungarotoxin for nicotinic receptor blockade

  2026-08-18

  α-Bungarotoxin provides a high-affinity way to test α7 nicotinic acetylcholine receptor dependence in neural, neuromuscular, and placental models. This guide translates recent necroptosis research into practical assay design, control selection, and troubleshooting strategies.

• Syringin N1347: Reliable Cell Assay Workflows

  2026-08-17

  Learn how Syringin (SKU N1347) can support reproducible cell viability, proliferation, cytotoxicity, and apoptosis research. This scenario-based guide covers assay interpretation, solvent compatibility, protocol optimization, RCC mechanism studies, and evidence-based product selection.

• FK866 (APO866): A Translational NAD Strategy

  2026-08-17

  FK866 (APO866) offers a precise way to interrogate NAMPT dependence, NAD depletion, mitochondrial injury, and treatment resistance. This thought-leadership analysis connects AML-focused metabolism research with emerging evidence that NAD biology shapes PARP inhibitor resistance, while outlining practical strategies for rigorous translational studies.

• Calpain Inhibitor I, ALLN: Practical Workflow

  2026-08-16

  Calpain Inhibitor I, ALLN (SKU A2602) is a cysteine-protease inhibitor for controlled studies of calpain and cathepsin contributions to apoptosis, inflammation, and ischemia-reperfusion injury. It is water-insoluble and should be prepared in DMSO or ethanol with matched vehicle controls; it is for research use only and does not provide a validated clinical or diagnostic protocol.

• Steroid Lysis of Protoplasts: Mechanistic Insights

  2026-08-15

  Smith and Shay used osmotically fragile Sarcina lutea protoplasts to separate cell-wall effects from direct membrane injury by synthetic antimicrobial steroids. Their protection and surfactant experiments support membrane disruption as a principal mechanism while also showing that polyamines, divalent cations, aggregation, and lipid environments can strongly alter the lysis readout.

• Human SAN-Plexus Assembloids Model Pacemaker Maturation

  2026-08-14

  The reference study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac ganglionated plexus, and atrial-like tissues to model neuro-cardiac control of pacemaker maturation. By integrating electrophysiology with human SAN spatial transcriptomics, the authors identify a CGPO-derived prosaposin–GPR37 signaling program that supports pacemaker development and provides a framework for studying conduction dysfunction.

• Cx43/NF-κB Control of AngII Macrophage Polarization

  2026-08-14

  The reference study shows that angiotensin II drives RAW264.7 macrophages toward an M1-like inflammatory phenotype through coordinated activation of Cx43 and NF-κB p65. Pharmacologic inhibition of either component reduced inflammatory markers, positioning Cx43 as a mechanistic entry point for studying macrophage-mediated cardiovascular inflammation while also defining important limits for translation to other systems.

• Machine Learning for Senolytic Discovery

  2026-08-13

  The Nature Communications study developed machine-learning models from published screening data to identify senolytic candidates despite limited and heterogeneous training datasets. Computational screening followed by human-cell validation identified ginkgetin, periplocin, and oleandrin, demonstrating a cost-conscious route for early senolytic discovery while highlighting the need for cell-type and senescence-context controls.

• Risedronate Sodium: Assay Design Beyond Bone

  2026-08-13

  Risedronate Sodium is an FPP synthase inhibitor whose value extends from osteoclast-mediated bone resorption inhibition to carefully bounded lung and cancer research. This article presents an assay-centered framework that distinguishes direct evidence, cross-domain hypotheses, delivery effects, and practical endpoint selection.

• Ibrexafungerp Activity Against Resistant Candida auris

  2026-08-12

  Wiederhold and colleagues combined broth microdilution testing with a delayed-treatment murine model to evaluate ibrexafungerp against fluconazole-resistant Candida auris. The study found consistent in vitro activity and improved survival and kidney fungal-burden outcomes with ibrexafungerp and caspofungin, supporting glucan-targeted therapy as a research focus for invasive candidiasis.

• PPP1R3G/PP1γ Control RIPK1-Driven Cell Death

  2026-08-12

  The reference study identifies PPP1R3G and PP1γ as a phosphatase module that removes inhibitory phosphorylation from RIPK1, enabling RIPK1-dependent apoptosis and type I necroptosis. By combining a sensitized CRISPR screen, genetic rescue, biochemical analysis, and an in vivo TNF challenge, the work defines a mechanistic link between TNFR1 complex I organization, RIPK1 kinase activation, and systemic inflammatory injury.

• Spleen-Targeted Neoantigen mRNA Vaccine in HCC

  2026-08-11

  Lin et al. developed a spleen-targeted neoantigen mRNA vaccine that produced strong antitumor activity in orthotopic hepatocellular carcinoma models. The study identifies ISG15⁺ CD8⁺ T cells and GZMA–F2R signaling as mechanistic links between vaccination, antigen-presenting cells, and tertiary lymphoid structure formation.

• GANT61: From GLI Biology to Translational Strategy

  2026-08-11

  GANT61 offers a practical way to interrogate GLI1/2-dependent transcription, tumor-cell plasticity, and immune-evasive biology. This article connects recent GLI2 findings to experimental design, translational decision-making, and rational combination studies while defining the limitations of a research-grade GLI inhibitor.

• BIIE 0246: Y2R Antagonist Research Workflows

  2026-08-10

  BIIE 0246 gives researchers a selective way to separate Y2 receptor signaling from Y1 receptor mechanisms in neural, gut, feeding, and exploratory neurocardiac assays. This guide translates its binding and functional profile into practical workflows, controls, and troubleshooting strategies without overstating evidence from emerging cardiovascular models.

• SB-505124 Hydrochloride: ALK Signaling Workflow

  2026-08-09

  SB-505124 hydrochloride offers a reversible way to interrogate ALK4/5/7-dependent TGF-β signaling, from Smad phosphorylation and fibroblast activation to mechanically relevant cancer-cell phenotypes. This workflow connects pathway inhibition with stiffness, immune-clearance, fibrosis, and formulation assays while separating established product performance from practical optimization recommendations.

573 records 9/39 page Previous Next First page 上5页 678910 下5页 Last page